Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

HIFU Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids

A legfontosabb adatok

Ki végzi
Chinese University of Hong Kong
Hol
Hongkong1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toboroz
Résztvevők
112 fő, tervezett
Kezdés
2025. febr. 6.
Várható befejezés
2027. dec. 31.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • High-Intensity Focused Ultrasound (HIFU)
  • myomectomy
A regiszteradat frissítve
2026. március 27.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for women aged 18 to 50 with uterine fibroids that cause symptoms. It compares HIFU, a focused ultrasound treatment, with myomectomy, surgery to remove the fibroids.

Életkor
18 to 50 years
Nem
Women only
A betegség stádiuma
Fibroids that cause heavy periods, pressure or pelvic pain. The main fibroid is in the muscle wall of the womb and measures ≥ 3cm (1,2 in) and ≤ 10cm (3,9 in) on imaging. Uterine size ≤18 weeks on physical exam. Before or around menopause, with FSH less than 25 mIU/ml. BMI < 33 kg/m2 or abdominal wall thickness < 5 cm (2 in).
Korábbi kezelés
People who had radiation to the pelvis cannot join.
Biomarker vagy leletérték
FSH less than 25 mIU/ml

A részvétel fő kizáró okai

  • Pregnancy, breastfeeding or menopause
  • Other pelvic masses or disease, such as endometriosis, ovarian tumour, pelvic infection or adenomyosis, or possible cancer of the womb
  • Fibroids that doubled in size in 6 months, or fibroids in the cervix or broad ligament
  • Past or current blood clots or stroke, clotting problems, or medicines that affect clotting
  • Cannot have MRI, cannot lie face down for more than 2 hours, severe obesity, or a large scar on the belly in the treatment path

A regiszter feltételei, szó szerint

Mind a 21 feltétel megnézéseKevesebb

Ki vehet részt

  • Age 18 - 50 years-old
  • Pre or peri menopausal with FSH less than 25 mIU/ml
  • BMI < 33 kg/m2 or abdominal wall thickness < 5 cm
  • Uterine size ≤18 weeks based on physical exam assessment
  • Dominant intramural fibroid ≥ 3cm and ≤ 10cm on imaging
  • Symptomatic fibroids cause menorrhagia, pressure, or pelvic pain
  • Willing and able to give informed consent

Ki nem vehet részt

  • Coagulation problem or using medication which affect clotting function
  • Patient with other pelvic mass indicated by history or magnetic resonance imaging (MRI) such as endometriosis, abnormal adnexal mass, ovarian tumor, acute or chronic pelvic inflammatory disease
  • Uterine premalignant or malignant pathologies or pathology other than uterine fibroid cannot be ruled out through detailed clinical assessment and investigation including MRI
  • History of or current thromboembolic event (deep vein thrombosis, pulmonary embolus, stroke)
  • History of pelvic irradiation
  • Morbid obesity
  • Inability to lie in a prone position for more than 2 hours
  • Extensive abdominal scar on the acoustic channel
  • Women with pregnancy, lactation or menopause
  • Rapid growth of fibroids, defined as a doubling in size in 6 months
  • Pedunculated submucosal or subserosal fibroid of size ≧5cm and with a stalk less than 25% of the maximal fibroid diameter
  • Cervical/ broad ligament fibroid
  • Contraindication to MRI due to severe claustrophobia or implanted metallic device
  • Co-existing adenomyosis

A fő feltételek kérdésként

Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.

  • 18 és 50 év között vagy?

Ez a vizsgálat jelenleg itt érhető el: Hongkong.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

The goal of this clinical trial is to learn if High-Intensity Focused Ultrasound (HIFU) is as effective as myomectomy for treating symptomatic uterine fibroids in women aged 18 to 50. The main questions it aims to answer are:

A teljes eredeti leírásKevesebb

Is HIFU as effective as myomectomy in improving quality of life for women with uterine fibroids? How do the recovery times and complications compare between HIFU and myomectomy? Researchers will compare the outcomes of women receiving HIFU treatment to those undergoing myomectomy to see if HIFU offers similar or better results with fewer complications.

Participants will:

Undergo an initial medical assessment, including ultrasounds and blood tests. Receive either HIFU treatment or myomectomy based on random assignment. Complete questionnaires about their symptoms and quality of life before treatment and at follow-up visits (3 and 6 months post-treatment).

Be monitored for any complications and recovery progress during follow-up.

A vizsgálat 2 csoportja

  • HIFU groupMár használt kezelés, összehasonlításként

    All women in the HIFU group will undergo pelvic MRI scans, including T1- and T2-weighted imaging, for fibroid localization and treatment planning. The HIFU treatment will utilize the Haifu JC 200 system under real-time ultrasound guidance, with participants positioned prone in a water-filled generator chamber. Conscious sedation will be administered using fentanyl and midazolam, adjusted based on pain tolerance. Acoustic output power will range from 300 to 400W, with treatment energy tailored to participant feedback and ultrasound imaging. Post-procedure, participants will be monitored for 4-6 hours, with discharge criteria including dietary tolerance and urination. Data on pain, skin condition, and adverse events will be collected. Before discharge, participants will complete a Client Satisfaction questionnaire and will receive analgesics, along with instructions to document menstrual cycles using the PBAC chart.

    Kezelés: High-Intensity Focused Ultrasound (HIFU)

  • Myomectomy groupPlacebo, összehasonlításként

    Myomectomy will be performed using laparoscopic, open, or hysteroscopic techniques by accredited HKCOG gynecologists. Key metrics such as blood loss, intraoperative and postoperative complications, whether the endometrial cavity was entered, length of hospital stay, need for blood transfusion, and readmissions will be meticulously recorded. A complete blood count will be assessed approximately 6 hours post-surgery. Patients will be monitored for blood pressure and pulse per departmental protocol. Typically, those undergoing hysteroscopic myomectomy are discharged the same day, while laparoscopic or open myomectomy patients are discharged within 1 to 3 days. Before discharge, women will complete a Client Satisfaction questionnaire and will receive analgesics, along with instructions to document their menstrual cycle, flow, and dysmenorrhea using the PBAC chart.

    Kezelés: myomectomy

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
A Randomized Controlled Trial of High-Intensity Focused Ultrasound (HIFU) Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 15.
Kérdések a feltételekről
Forrás: NCT06692335: ki vehet részt
A regiszteradat frissítve
2026. március 27.